EIF2S2 transcriptionally upregulates HIF1α to promote gastric cancer progression via activating PI3K/AKT/mTOR pathway
Carcinogenesis · 2024
DOI: 10.1093/carcin/bgae043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2024. Verfasst von Zhiyong Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Hypoxia-Inducible Factor 1, alpha Subunit, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Beijing Medical Award Foundation.
Abstract (Originalsprache)
Eukaryotic translation initiation factor 2 subunit beta (EIF2S2) is a protein that controls protein synthesis under various stress conditions and is abnormally expressed in several cancers. However, there is limited insight regarding the expression and molecular role of EIF2S2 in gastric cancer. In this study, we identified the overexpression of EIF2S2 in gastric cancer by immunohistochemical staining and found a positive correlation between EIF2S2 expression and shorter overall survival and disease-free survival. Functionally, we revealed that EIF2S2 knockdown suppressed gastric cancer cell proliferation and migration, induced cell apoptosis, and caused G2 phase cell arrest. Additionally, EIF2S2 is essential for in vivo tumor formation. Mechanistically, we demonstrated that EIF2S2 transcriptionally regulated hypoxia-inducible factor-1 alpha (HIF1α) expression by NRF1. The promoting role of EIF2S2 in malignant behaviors of gastric cancer cells depended on HIF1α expression. Furthermore, the PI3K/AKT/mTOR signaling was activated upon EIF2S2 overexpression in gastric cancer. Collectively, EIF2S2 exacerbates gastric cancer progression via targeting HIF1α, providing a fundamental basis for considering EIF2S2 as a potential therapeutic target for gastric cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Road, Wuhan 430022, Hubei Province, China.
- Department of Oncology, Changhai Hospital, Naval Medical University, No. 168 Changhai Road, Shanghai 200433, China.
- Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin 150081, Heilongjiang Province, China.
- Department of Oncology, Shanghai East Hospital, School of Medicine, Tongji University, No. 150 Jimo Road, Shanghai 200120, China.
ORCID-Profile: Hongfeng Zhang
Förderung
- Beijing Medical Award Foundation
Zitieren
APA
Wang, Z., Zhang, Y., Xue, Y., Huang, W., & Zhang, H. (2024). EIF2S2 transcriptionally upregulates HIF1α to promote gastric cancer progression via activating PI3K/AKT/mTOR pathway. Carcinogenesis. https://doi.org/10.1093/carcin/bgae043
Vancouver
Wang Z, Zhang Y, Xue Y, Huang W, Zhang H. EIF2S2 transcriptionally upregulates HIF1α to promote gastric cancer progression via activating PI3K/AKT/mTOR pathway. Carcinogenesis. 2024. doi:10.1093/carcin/bgae043
BibTeX
@article{Wang2024,
author = {Wang, Zhiyong and Zhang, Yingyi and Xue, Yingwei and Huang, Wei and Zhang, Hongfeng},
title = {EIF2S2 transcriptionally upregulates HIF1α to promote gastric cancer progression via activating PI3K/AKT/mTOR pathway},
journal = {Carcinogenesis},
year = {2024},
doi = {10.1093/carcin/bgae043}
}
EUVIMED